Bydureon bcise and Atrial fibrillation/flutter - a phase IV clinical study of FDA data

Summary:

Atrial fibrillation/flutter is reported as a side effect among people who take Bydureon bcise (exenatide), especially for people who are male, 60+ old, also take Bydureon, and have Type 2 diabetes.

The phase IV clinical study analyzes which people have Atrial fibrillation/flutter when taking Bydureon bcise. It is created by eHealthMe based on reports of 13,811 people who have side effects when taking Bydureon bcise from the FDA, and is updated regularly.

What is Bydureon bcise?

Bydureon bcise has active ingredients of exenatide. eHealthMe is studying from 13,812 Bydureon bcise users. Check the latest studies of Bydureon bcise.

What is Atrial fibrillation/flutter?

Atrial fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles) is found to be associated with 2,362 drugs and 3,843 conditions by eHealthMe. Check the latest studies of Atrial fibrillation/flutter.

On Jul, 11, 2026

13,811 people reported to have side effects when taking Bydureon bcise.
Among them, 38 people (0.28%) have Atrial fibrillation/flutter.

Could Bydureon bcise cause Atrial fibrillation/flutter?

Among these 38 people:

What is the gender of people who have Atrial fibrillation/flutter when taking Bydureon bcise? *

female: 31.58 %
male: 68.42 %

What is the age of people who have Atrial fibrillation/flutter when taking Bydureon bcise? *

What are other drugs people take besides Bydureon bcise? *

What are other side effects people have besides Atrial fibrillation/flutter? *

Injection Site Haemorrhage (bleeding from injection site): 15 people, 39.47%
Weight Decreased: 8 people, 21.05%
Blood Glucose Increased: 8 people, 21.05%
Injection Site Pain: 6 people, 15.79%
Injection Site Mass: 6 people, 15.79%
Cardiac Disorder: 6 people, 15.79%
Pain: 5 people, 13.16%
Glycosylated Haemoglobin Increased: 5 people, 13.16%
Drowsiness: 4 people, 10.53%
Drug Ineffective: 4 people, 10.53%

What are the existing conditions these people have? *

Type 2 Diabetes: 26 people, 68.42%
Diabetes: 11 people, 28.95%
High Blood Cholesterol: 10 people, 26.32%
Cardiac Disorder: 7 people, 18.42%
Blood Pressure Abnormal: 6 people, 15.79%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 13.16%
Muscle Spasms (muscle contraction): 4 people, 10.53%
High Blood Pressure: 3 people, 7.89%
Stress And Anxiety: 3 people, 7.89%
Prostatomegaly (enlargement of the prostate): 3 people, 7.89%

* Approximation only. Some reports may have incomplete information.

Do you take Bydureon bcise and have Atrial fibrillation/flutter?

- Check whether Atrial fibrillation/flutter is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Bydureon bcise:

Bydureon bcise (13,812 reports)

Browse all side effects of Bydureon bcise:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Atrial fibrillation/flutter:

Atrial fibrillation/flutter (2,362 drugs)

Browse all the conditions that are associated with Atrial fibrillation/flutter:

Atrial fibrillation/flutter (3,843 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on exenatide (the active ingredients of Bydureon bcise) and Bydureon bcise (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.